The FDA had proposed removing phenylephrine, a widely used ingredient to treat nasal congestion, from over-the-counter cold ...

The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.

The companies’ monoclonal antibody met co-primary endpoints in a Phase III trial in patients with chronic rhinosinusitis with ...

This follows an extensive review that found the drug ineffective for treating nasal congestion. Oral phenylephrine, widely ...

A panel last year said it found evidence the ingredient, used in many popular medicines, did not aid with nasal congestion.

The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an ...

demonstrated a statistically significant and clinically meaningful reduction in the size of nasal polyps and reduced nasal congestion compared to placebo. WAYPOINT is a randomized, double-blind trial ...

Share on Facebook Share on Twitter The Food and Drug Administration (“FDA”) said on Thursday that they will seek to pull the ...

Cold and flu season is upon us and Americans will be flocking to pharmacy shelves to pick up some medicine to alleviate their ...

I take 5 mg of Crestor and a multivitamin daily. I recently took a generic 12-hour, maximum-strength nasal decongestant to ...

Citing topline data from their Phase 3 WAYPOINT trial, the companies said that the antibody therapy reduced the size of nasal ...

Discover the similarities between Covid, flu, and the common cold, and learn how to diagnose each one accurately with testing ...